Praxis Precision Medicines

IPO

Home - Praxis Medicines

Public · United States · Founded 2020 · $110.0M raised

Founded
2020
Business Model
B2B
Total Funding
$110.0M
Last Round
$110.0M Series CMay 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Praxis Precision Medicines is a fully integrated central nervous system precision neuroscience biopharmaceutical company. It uses precision neuroscience to identify and target biologically defined mechanisms of disease, integrating insights from human biology, genetics, translational science, and patient experience. Informed by genetic epilepsies and broader CNS biology, its portfolio spans movement disorders and epilepsy across small-molecule and antisense platforms. Cerebrum develops orally available precision therapies, and Solidus is a targeted antisense oligonucleotide discovery engine for patients and families affected by complex brain disorders.

Summary

Praxis Precision Medicines is a Biotech company based in United States, founded in 2020. It has raised $110.0M in total across 1 round, most recently a $110.0M Series C round in May 2020. Investors include Eventide Asset Management, Vida Ventures and OCV Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOOct 2020
$190.0M

Sign up to see all 2 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Praxis Precision Medicines on Indexed.vc
<a href="https://indexed.vc/companies/praxis-precision-medicines"><img src="https://indexed.vc/api/badge/company/praxis-precision-medicines" alt="Praxis Precision Medicines on Indexed.vc" width="260" height="76" /></a>